Betoptic-S Eye Drops (Betaxolol Hydrochloride)

Adult eye dose

Instill 1 drop twice daily, usually. In some patients, it may take several weeks for the intraocular pressure-lowering response to this medicine to stabilize. Intraocular pressure should be monitored continuously during the first month of treatment; thereafter, the individual target intraocular pressure should be determined at the physician’s discretion. In patients already being treated with another glaucoma medicine, continue the current medicine and add 1 drop of this medicine twice daily. On the second day, completely discontinue the previous glaucoma medicine and continue treatment with this medicine. Because intraocular pressure varies during the day in each individual, whether the twice-daily regimen is sufficient should be determined by measuring intraocular pressure at different times. Since an intraocular pressure of 22 mmHg or lower is not adequate for controlling glaucoma, drug therapy should be individualized. If the patient’s intraocular pressure is not adequately controlled with this method, this medicine may be administered in combination with pilocarpine, other miotics, epinephrine, or carbonic anhydrase inhibitors. In patients using multiple glaucoma medicines concomitantly, treatment should be individualized. Adjust one medicine at a time, at intervals of at least 1 week. The recommended method is to continue the current medicines and instill 1 drop of this medicine twice daily. The following day, discontinue one of the other glaucoma medicines; the remaining medicines may be reduced or discontinued according to the patient’s response to treatment. The physician may discontinue some or all of the other glaucoma medicines.

This medication is an eye drop solution and should not be used in certain patients. Patients who are allergic to this medicine or its components, or have heart conduction issues, history of heart shock, or heart failure should not use this medication. Patients with diabetes who use insulin or hypoglycemic agents should be cautious as this medication can mask hypoglycemic symptoms. Patients with hyperthyroidism should use this medication cautiously as it may obscure symptoms such as tachycardia. Patients with severely impaired lung function or asthma are at risk for respiratory distress or bronchospasm when using this medication. Patients with cardiovascular diseases or hypotension should carefully evaluate their condition before using this medication and should monitor for adverse reactions. Patients with severe peripheral blood circulation disorders should also be cautious when using this medication. This medication can cause temporary discomfort, tearing, itching, redness, blurred vision, and in rare cases keratitis or abnormal pupil reactions. Systemic side effects such as insomnia, neurological symptoms, bradycardia, and respiratory distress have been reported infrequently. During the use of this medication, be aware of changes in intraocular pressure or systemic beta-blockade effects, and avoid sudden discontinuation if thyroid dysfunction is suspected. Patients should wait until temporary blurred vision resolves before driving or operating machinery. It is advisable not to use this medication during pregnancy unless strictly necessary, and it should be used cautiously while breastfeeding. The safety for children has not been adequately established. When instilling, be careful not to let the tip of the container touch the eye, and use within one month after opening. It should be stored in a cool and dry place out of reach of children. In case of overdose, it is recommended to wash the eyes with warm water.

• Discomfort
• tearing
• decreased corneal sensitivity
• erythema
• itching
• corneal punctate discoloration
• keratitis
• pupillary atony
• edema
• glare

This medication must be stored in a tightly closed container to avoid exposure to air or moisture. Additionally, it is best to keep the medication at room temperature between 1°C and 30°C, away from extremes of heat or cold.

Appearance

White to almost white suspension

Package unit

5mL/bottle